Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
DEL PRIS
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionTwo Sigma Advisers, Lp
Latest Disclosed Ownership152,600 shares
Latest Disclosed Value $ 1,585,514
Two Sigma Advisers, Lp reports 20.92% increase in ownership of KUR / Kura Oncology, Inc.

On February 17, 2026 - Two Sigma Advisers, Lp filed a 13F-HR form disclosing ownership of 152,600 shares of Kura Oncology, Inc. (DE:KUR) valued at $1,329,146 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 126,200 shares of Kura Oncology, Inc.. This represents a change in shares of 20.92% during the quarter. The current value of the position is $1,153,656 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F KURA ONCOLOGY COM 50127T109 152,600 26,400 20.92 1,586 42.03 0.0031
2025-11-14 2025-09-30 13F KURA ONCOLOGY COM 50127T109 126,200 -316,300 -71.48 1,117 -56.29 0.0022
2025-08-14 2025-06-30 13F KURA ONCOLOGY COM 50127T109 442,500 163,900 58.83 2,553 38.90 0.0052
2025-05-15 2025-03-31 13F KURA ONCOLOGY COM 50127T109 278,600 36,400 15.03 1,839 -12.85 0.0041
2025-02-14 2024-12-31 13F KURA ONCOLOGY COM 50127T109 242,200 144,201 147.15 2,110 10.19 0.0049
2024-11-14 2024-09-30 13F KURA ONCOLOGY COM 50127T109 97,999 -16,701 -14.56 1,915 -18.93 0.0045
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM 50127T109 114,700 28,200 32.60 2,362 27.97 0.0053
2024-05-15 2024-03-31 13F KURA ONCOLOGY COM 50127T109 86,500 64,900 300.46 1,845 495.16 0.0043
2024-02-14 2023-12-31 13F KURA ONCOLOGY COM 50127T109 21,600 -2,300 -9.62 311 42.86 0.0007
2023-11-14 2023-09-30 13F KURA ONCOLOGY COM 50127T109 23,900 3,700 18.32 218 1.88 0.0006
2023-08-14 2023-06-30 13F KURA ONCOLOGY COM 50127T109 20,200 -23,200 -53.46 214 -59.81 0.0005
2023-05-15 2023-03-31 13F KURA ONCOLOGY COM 50127T109 43,400 -151,900 -77.78 531 -78.13 0.0014
2023-02-14 2022-12-31 13F KURA ONCOLOGY COM 50127T109 195,300 -171,700 -46.78 2,424 -51.67 0.0068
2022-11-14 2022-09-30 13F KURA ONCOLOGY COM 50127T109 367,000 116,100 46.27 5,013 9.00 0.0145
2022-08-15 2022-06-30 13F KURA ONCOLOGY COM 50127T109 250,900 -16,200 -6.07 4,599 7.08 0.0130
2022-05-16 2022-03-31 13F KURA ONCOLOGY COM 50127T109 267,100 -157,700 -37.12 4,295 -27.78 0.0114
2022-02-14 2021-12-31 13F KURA ONCOLOGY COM 50127T109 424,800 -162,900 -27.72 5,947 -45.98 0.0149
2021-11-15 2021-09-30 13F KURA ONCOLOGY COM 50127T109 587,700 -111,000 -15.89 11,008 -24.44 0.0285
2021-08-16 2021-06-30 13F KURA ONCOLOGY COM 50127T109 698,700 65,300 10.31 14,568 -18.64 0.0384
2021-05-17 2021-03-31 13F KURA ONCOLOGY COM 50127T109 633,400 137,000 27.60 17,906 10.45 0.0492
2021-02-16 2020-12-31 13F KURA ONCOLOGY COM 50127T109 496,400 320,900 182.85 16,212 201.51 0.0433
2020-11-16 2020-09-30 13F KURA ONCOLOGY COM 50127T109 175,500 -73,600 -29.55 5,377 32.44 0.0154
2020-09-15 2020-06-30 13F/A-1 KURA ONCOLOGY COM 50127T109 249,100 7,100 2.93 4,060 68.60 0.0119
2020-08-14 2020-06-30 13F KURA ONCOLOGY COM 50127T109 249,100 7,100 4,060 11,732.0516
2020-05-15 2020-03-31 13F KURA ONCOLOGY COM 50127T109 242,000 107,500 79.93 2,408 30.23 0.0092
2020-02-14 2019-12-31 13F KURA ONCOLOGY COM 50127T109 134,500 84,100 166.87 1,849 141.70 0.0043
2019-11-14 2019-09-30 13F KURA ONCOLOGY COM 50127T109 50,400 13,200 35.48 765 4.51 0.0019
2019-08-14 2019-06-30 13F KURA ONCOLOGY COM 50127T109 37,200 18,600 100.00 732 136.89 0.0018
2019-05-15 2019-03-31 13F KURA ONCOLOGY COM 50127T109 18,600 4,300 30.07 309 53.73 0.0008
2019-02-14 2018-12-31 13F KURA ONCOLOGY COM 50127T109 14,300 300 2.14 201 -17.96 0.0005
2018-11-14 2018-09-30 13F KURA ONCOLOGY COM 50127T109 14,000 -3,800 -21.35 245 -24.38 0.0006
2018-08-14 2018-06-30 13F KURA ONCOLOGY COM 50127T109 17,800 17,800 324 0.0009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.